Patents by Inventor Georg Groetzbach

Georg Groetzbach has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treatment of cardiomyopathy and of endothelial dysfunction
    Publication number: 20050276785
    Abstract: The present invention relates to pharmaceutical compositions comprising a therapeutically effective dose of an isolated interferon (IFN) or IFN mutein for treatment of cardiomyopathy and of endothelial dysfunction, and to methods of treating cardiomyopathy and methods of treating endothelial dysfunction using such pharmaceutical compositions. Particularly, the pharmaceutical compositions of the present invention comprise a therapeutically effective dose of an isolated, human IFN, or IFN mutein that is a variant of an isolated human IFN, e.g., an isolated, native, human IFN? or an isolated, native, human IFN?.
    Type: Application
    Filed: June 7, 2005
    Publication date: December 15, 2005
    Applicant: Schering Aktiengesellschaft
    Inventors: Georg Groetzbach, Joachim-Friedrich Kapp, Uwe Kuehl, Heinz-Peter Schultheiss, Olaf Sowade, Claus-Steffen Stuerzebecher